Explore Viatris News
View Our Media Library
Explore Viatris News
Press Releases
Aug 8, 2022

Reports Total Revenues of $4.12 Billion; U.S. GAAP Net Earnings of $314 Million; Adjusted EBITDA of $1.48 Billion; U.S. GAAP Net Cash Provided by Operating Activities of $803 Million; and Free...

Jul 5, 2022

FOR IMMEDIATE RELEASE - PITTSBURGH – July 5, 2022 – Mylan Pharmaceuticals Inc., a Viatris company, is voluntarily recalling one batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100...

Jul 1, 2022

Viatris Inc. (NASDAQ: VTRS) plans to release its second quarter 2022 financial results on Monday, August 8 before the open of the U.S. financial markets. Chief Executive Officer Michael Goettler,...

All Press Releases

Media Contacts

Global Communications
1000 Mylan Blvd.
Canonsburg, PA 15317